Asosiy kontentga oʻtish
Maqola

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

Ann M. ArvinStanford University School of Medicine, Stanford, CA, USA. [email protected]Katja FinkHumabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, SwitzerlandMichael SchmidHumabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, SwitzerlandAndrea L. CathcartVir Biotechnology, San Francisco, CA, USARoberto SpreaficoVir Biotechnology, San Francisco, CA, USAColin Havenar‐DaughtonVir Biotechnology, San Francisco, CA, USAAntonio LanzavecchiaVir Biotechnology, San Francisco, CA, USADavide CortiHumabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, SwitzerlandHerbert W. VirginVir Biotechnology, San Francisco, CA, USA. [email protected]
2020en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba